ING Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $18.3M | Hold |
|
|||||
|
2023
Q4 | $20.2M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $516K | Sell |
|
|||||
|
2018
Q4 | $757K | Sell |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $352K | Buy |
|
|||||
|
2018
Q1 | $295K | Sell |
|
|||||
|
2017
Q4 | $421K | Sell |
|
|||||
|
2017
Q3 | $507K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $57.4M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.69M | Buy |
|
|||||
|
2015
Q3 | $1.63M | Buy |
|
|||||
|
2015
Q2 | $339K | Sell |
|
|||||
|
2015
Q1 | $32M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $13.5M | Buy |
|